KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Acquisitions (2016 - 2023)

CareDx (CDNA) has disclosed Acquisitions for 8 consecutive years, with $2.1 million as the latest value for Q3 2023.

  • Quarterly Acquisitions rose 317.32% to $2.1 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Jun 2024, down 58.19% year-over-year, with the annual reading at $6.7 million for FY2023, 995.41% up from the prior year.
  • Acquisitions hit $2.1 million in Q3 2023 for CareDx, down from $4.6 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $11.9 million in Q4 2021 to a low of -$43000.0 in Q2 2021.
  • Historically, Acquisitions has averaged $2.8 million across 4 years, with a median of $2.1 million in 2019.
  • Biggest five-year swings in Acquisitions: plummeted 83.96% in 2019 and later soared 337.21% in 2022.
  • Year by year, Acquisitions stood at $111000.0 in 2019, then soared by 10651.35% to $11.9 million in 2021, then tumbled by 95.74% to $508000.0 in 2022, then skyrocketed by 317.32% to $2.1 million in 2023.
  • Business Quant data shows Acquisitions for CDNA at $2.1 million in Q3 2023, $4.6 million in Q1 2023, and $508000.0 in Q3 2022.